OMEGA HEALTHCARE INVESTORS INC
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.2B | $1.1B | $949.7M | $878.2M | $1.1B |
| Operating expenses | $688.0M | $648.9M | $793.6M | $799.7M | $777.0M |
| Pretax income | $624.4M | $420.7M | $255.6M | $436.1M | $416.1M |
| Income tax expense | $14.7M | $10.9M | $6.3M | $4.6M | $3.8M |
| Net income | $590.2M | $406.3M | $242.2M | $438.8M | $428.3M |
| Balance Sheet | |||||
| Cash and equivalents | $27.0M | $518.3M | $442.8M | $297.1M | $20.5M |
| Total assets | $10.0B | $9.9B | $9.1B | $9.4B | $9.6B |
| Total liabilities | $4.6B | $5.2B | $5.4B | $5.6B | $5.5B |
| Stockholders' equity | $5.2B | $4.5B | $3.6B | $3.6B | $3.9B |
| Cash Flow Statement | |||||
| Cash from operations | $878.6M | $749.4M | $617.7M | $625.7M | $722.1M |
| Depreciation and amortization | $325.2M | $304.6M | $319.7M | $332.4M | $342.0M |
| Stock-based compensation | $44.2M | $36.7M | $35.1M | $27.3M | $21.4M |
| Dividends paid | $780.4M | $685.4M | $643.9M | $632.9M | $637.6M |
| Share repurchases | — | — | — | $142.3M | — |
| Impairments | $0 | $0 | $0 | $0 | $0 |
Shares outstanding 297.8M · Free float 92.5%
Annual filing data through FY ended December 31, 2025; float as of July 11, 2026.